{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:44:45Z","timestamp":1792788285505,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014440","name":"Spain Ministry of Science Innovation and Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ymthe.2026.09.040","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:09:32Z","timestamp":1791562172000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inhibition of CCN2\/CTGF prevents heterotopic ossification in fibrodysplasia ossificans progressiva"],"prefix":"10.1016","author":[{"given":"Alexandre","family":"Deber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Farf\u00e1n-Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ferrer-Roig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meritxell","family":"Rovira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9673-9405","authenticated-orcid":false,"given":"Francesc","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.09.040_bib1","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.158996","article-title":"Contemporary perspectives on heterotopic ossification","volume":"7","author":"Hwang","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2026.09.040_bib2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.molmed.2024.08.010","article-title":"Fibrodysplasia ossificans progressiva emerges from obscurity","volume":"31","author":"Kaplan","year":"2024","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymthe.2026.09.040_bib3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/dvdy.387","article-title":"BMP signaling and skeletal development in fibrodysplasia ossificans progressiva (FOP)","volume":"251","author":"Towler","year":"2022","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.ymthe.2026.09.040_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bone.2017.09.014","article-title":"Clinical staging of Fibrodysplasia Ossificans Progressiva (FOP)","volume":"109","author":"Pignolo","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.ymthe.2026.09.040_bib5","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2106\/JBJS.I.00705","article-title":"Early mortality and cardiorespiratory failure in patients with fibrodysplasia ossificans progressiva","volume":"92","author":"Kaplan","year":"2010","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.ymthe.2026.09.040_bib6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/14656566.2025.2452938","article-title":"Palovarotene in fibrodysplasia ossificans progressiva: review and perspective","volume":"26","author":"Verheij","year":"2025","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ymthe.2026.09.040_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-02872-2","article-title":"Activin-dependent signaling in fibro\/adipogenic progenitors causes fibrodysplasia ossificans progressiva","volume":"9","author":"Lees-Shepard","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.09.040_bib8","article-title":"Inhibition of overactive TGF-\u03b2 attenuates progression of heterotopic ossification in mice","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.09.040_bib9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ng1783","article-title":"A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva","volume":"38","author":"Shore","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2026.09.040_bib10","doi-asserted-by":"crossref","first-page":"36990","DOI":"10.1074\/jbc.M112.365932","article-title":"Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva","volume":"287","author":"Chaikuad","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.09.040_bib11","doi-asserted-by":"crossref","first-page":"303ra137","DOI":"10.1126\/scitranslmed.aac4358","article-title":"ACVR1 R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A","volume":"7","author":"Hatsell","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.09.040_bib12","doi-asserted-by":"crossref","first-page":"15438","DOI":"10.1073\/pnas.1510540112","article-title":"Neofunction of ACVR1 in fibrodysplasia ossificans progressiva","volume":"112","author":"Hino","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.09.040_bib13","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201910567","article-title":"Inhibition of phosphatidylinositol 3-kinase \u03b1 (PI3K\u03b1) prevents heterotopic ossification","volume":"11","author":"Valer","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2026.09.040_bib14","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1002\/jbmr.3235","article-title":"The Expansion of Heterotopic Bone in Fibrodysplasia Ossificans Progressiva Is Activin A-Dependent","volume":"32","author":"Upadhyay","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ymthe.2026.09.040_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115473","article-title":"Activin A does not drive post-traumatic heterotopic ossification","volume":"138","author":"Hwang","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.ymthe.2026.09.040_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb2233","article-title":"A self-amplifying loop of YAP and SHH drives formation and expansion of heterotopic ossification","volume":"13","author":"Cong","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.09.040_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn3486","article-title":"Primary cilia mediate skeletogenic BMP and Hedgehog signaling in heterotopic ossification","volume":"16","author":"He","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.09.040_bib18","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.144925","article-title":"Macrophage TGF\u03b2 signaling is critical for wound healing with heterotopic ossification after trauma","volume":"7","author":"Patel","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2026.09.040_bib19","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm.3869","article-title":"Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis of fibro\/adipogenic progenitors","volume":"21","author":"Lemos","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.09.040_bib20","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3389\/fphys.2019.01074","article-title":"Fibro\u2013Adipogenic Progenitors Cross-Talk in Skeletal Muscle: The Social Network","volume":"10","author":"Biferali","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ymthe.2026.09.040_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41536-021-00201-8","article-title":"Dynamics of skeletal muscle-resident stem cells during myogenesis in fibrodysplasia ossificans progressiva","volume":"7","author":"Stanley","year":"2022","journal-title":"NPJ Regen. Med."},{"key":"10.1016\/j.ymthe.2026.09.040_bib22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s12079-021-00631-5","article-title":"CCN proteins in the musculoskeletal system: current understanding and challenges in physiology and pathology","volume":"15","author":"Giusti","year":"2021","journal-title":"J. Cell Commun Signal"},{"key":"10.1016\/j.ymthe.2026.09.040_bib23","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.3390\/ijms25094692","article-title":"Connective Tissue Growth Factor: Regulation, Diseases, and Drug Discovery","volume":"25","author":"Ren","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.09.040_bib24","article-title":"CTGF as a multifunctional molecule for cartilage and a potential drug for osteoarthritis","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.ymthe.2026.09.040_bib25","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.bone.2011.06.033","article-title":"Differential roles of CCN family proteins during osteoblast differentiation: Involvement of Smad and MAPK signaling pathways","volume":"49","author":"Kawaki","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.ymthe.2026.09.040_bib26","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1097\/00007632-200209010-00009","article-title":"Possible Roles of CTGF\/Hcs24 in the Initiation and Development of Ossification of the Posterior Longitudinal Ligament","volume":"27","author":"Yamamoto","year":"2002","journal-title":"Spine (Phila. Pa. 1976)"},{"key":"10.1016\/j.ymthe.2026.09.040_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41413-024-00364-2","article-title":"A monoallelic variant in CCN2 causes an autosomal dominant spondyloepimetaphyseal dysplasia with low bone mass","volume":"12","author":"Li","year":"2024","journal-title":"Bone Res."},{"key":"10.1016\/j.ymthe.2026.09.040_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9060630","article-title":"Myd88 is not required for muscle injury-induced endochondral heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva","volume":"9","author":"Lyu","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ymthe.2026.09.040_bib29","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.3390\/ijms22105234","article-title":"Role of matricellular ccn proteins in skeletal muscle: Focus on ccn2\/ctgf and its regulation by vasoactive peptides","volume":"22","author":"Rebolledo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.09.040_bib30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12079-013-0204-8","article-title":"CCN2: A master regulator of the genesis of bone and cartilage","volume":"7","author":"Takigawa","year":"2013","journal-title":"J. Cell Commun. Signal."},{"key":"10.1016\/j.ymthe.2026.09.040_bib31","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/jbmr.3760","article-title":"Elevated BMP and Mechanical Signaling Through YAP1\/RhoA Poises FOP Mesenchymal Progenitors for Osteogenesis","volume":"34","author":"Stanley","year":"2019","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ymthe.2026.09.040_bib32","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1084\/jem.20111653","article-title":"TGF-\u03b2 synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth","volume":"209","author":"Fujii","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2026.09.040_bib33","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1101\/gad.192856.112","article-title":"Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP","volume":"26","author":"Liu-Chittenden","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymthe.2026.09.040_bib34","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1074\/jbc.M106826200","article-title":"Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene","volume":"277","author":"L\u00f3pez-Rovira","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.09.040_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.673599","article-title":"Mechanoregulation of YAP and TAZ in Cellular Homeostasis and Disease Progression","volume":"9","author":"Cai","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.ymthe.2026.09.040_bib36","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1101\/gad.1602907","article-title":"Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control","volume":"21","author":"Zhao","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymthe.2026.09.040_bib37","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.molcel.2007.12.022","article-title":"Yap1 Phosphorylation by c-Abl Is a Critical Step in Selective Activation of Proapoptotic Genes in Response to DNA Damage","volume":"29","author":"Levy","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2026.09.040_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/dvg.20201","article-title":"Generation of a mouse with conditionally activated signaling through the BMP receptor, ALK2","volume":"44","author":"Fukuda","year":"2006","journal-title":"Genesis"},{"key":"10.1016\/j.ymthe.2026.09.040_bib39","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3390\/biomedicines12040779","article-title":"Cellular and Molecular Mechanisms of Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva","volume":"12","author":"Mejias Rivera","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ymthe.2026.09.040_bib40","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202400381R","article-title":"FAPs orchestrate homeostasis of muscle physiology and pathophysiology","volume":"38","author":"Yin","year":"2024","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2026.09.040_bib41","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.trecan.2020.12.001","article-title":"Targeting CTGF in Cancer: An Emerging Therapeutic Opportunity","volume":"7","author":"Shen","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ymthe.2026.09.040_bib42","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.matbio.2018.03.007","article-title":"Connective tissue growth factor (CTGF) from basics to clinics","volume":"68\u201369","author":"Ramazani","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ymthe.2026.09.040_bib43","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1242\/dev.00505","article-title":"Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development","volume":"130","author":"Ivkovic","year":"2003","journal-title":"Development"},{"key":"10.1016\/j.ymthe.2026.09.040_bib44","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.1096\/fj.202000240RR","article-title":"Blocking CTGF\/CCN2 reduces established skeletal muscle fibrosis in a rat model of overuse injury","volume":"34","author":"Barbe","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2026.09.040_bib45","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1093\/hmg\/ddt352","article-title":"Reducing CTGF\/CCN2 slows down mdx muscle dystrophy and improves cell therapy","volume":"22","author":"Morales","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2026.09.040_bib46","article-title":"Pamrevlumab did not meet its primary endpoint for non-ambulatory patients with Duchenne Muscular Dystrophy: the LELANTOS-1 trial","author":"Connolly","year":"2025","journal-title":"medrxiv"},{"key":"10.1016\/j.ymthe.2026.09.040_bib47","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.trecan.2016.11.008","article-title":"Targeting TGF-\u03b2 Signaling in Cancer","volume":"3","author":"Colak","year":"2017","journal-title":"Trends in Cancer"},{"key":"10.1016\/j.ymthe.2026.09.040_bib48","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1089\/wound.2012.0365","article-title":"Integrin \u03b2 1: A Mechanosignaling Sensor Essential for Connective Tissue Deposition by Fibroblasts","volume":"2","author":"Leask","year":"2013","journal-title":"Adv. Wound Care (New. Rochelle)"},{"key":"10.1016\/j.ymthe.2026.09.040_bib49","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1074\/jbc.M109.049650","article-title":"FoxO proteins mediate hypoxic induction of connective tissue growth factor in endothelial cells","volume":"285","author":"Samarin","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.09.040_bib50","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.ymthe.2017.01.008","article-title":"Strategic Targeting of Multiple BMP Receptors Prevents Trauma-Induced Heterotopic Ossification","volume":"25","author":"Agarwal","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.09.040_bib51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1091\/mbc.E18-05-0311","article-title":"ACVR1 R206H FOP mutation alters mechanosensing and tissue stiffness during heterotopic ossification","volume":"30","author":"Haupt","year":"2019","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ymthe.2026.09.040_bib52","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/jbmr.2848","article-title":"Cellular Hypoxia Promotes Heterotopic Ossification by Amplifying BMP Signaling","volume":"31","author":"Wang","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ymthe.2026.09.040_bib53","article-title":"A glucocorticoid spike derails muscle repair to heterotopic ossification after spinal cord injury","volume":"5","author":"Alexander","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ymthe.2026.09.040_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101416","article-title":"Modeling the Control of TGF-\u03b2\/Smad Nuclear Accumulation by the Hippo Pathway Effectors","volume":"23","author":"Labibi","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.ymthe.2026.09.040_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201902931","article-title":"BMP-2 Signaling and Mechanotransduction Synergize to Drive Osteogenic Differentiation via YAP\/TAZ","volume":"7","author":"Wei","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ymthe.2026.09.040_bib56","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41580-018-0086-y","article-title":"Hippo\u2013YAP\/TAZ signalling in organ regeneration and regenerative medicine","volume":"20","author":"Moya","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"10.1016\/j.ymthe.2026.09.040_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz4028","article-title":"F I B R O S I S NUAK1 promotes organ fibrosis via YAP and TGF-F0E2\/SMAD signaling","volume":"14","author":"Zhang","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.09.040_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceb.2025.102476","article-title":"The recent advances and implications in cancer therapy for the hippo pathway","volume":"93","author":"Chan","year":"2025","journal-title":"Curr. Opin. Cell Biol"},{"key":"10.1016\/j.ymthe.2026.09.040_bib59","doi-asserted-by":"crossref","first-page":"e23057","DOI":"10.1096\/fj.202300568R","article-title":"Verteporfin attenuates trauma-induced heterotopic ossification of Achilles tendon by inhibiting osteogenesis and angiogenesis involving YAP\/\u03b2-catenin signaling","volume":"37","author":"Luo","year":"2023","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2026.09.040_bib60","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1038\/s41591-023-02561-8","article-title":"Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial","volume":"29","author":"Di Rocco","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.09.040_bib61","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/jama.2024.8693","article-title":"Pamrevlumab for Idiopathic Pulmonary Fibrosis: The ZEPHYRUS-1 Randomized Clinical Trial","volume":"332","author":"Raghu","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.ymthe.2026.09.040_bib62","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.91779.4","article-title":"PI3K\u03b1 inhibition blocks osteochondroprogenitor specification and the hyper-inflammatory response to prevent heterotopic ossification","volume":"12","author":"Valer","year":"2025","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2026.09.040_bib63","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/iej.13887","article-title":"Dental Stem Cells SV40, a new cell line developed in vitro from human stem cells of the apical papilla","volume":"56","author":"Sanz-Serrano","year":"2023","journal-title":"Int. Endod. J."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626008592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626008592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:20:29Z","timestamp":1792786829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626008592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":63,"alternative-id":["S1525001626008592"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.09.040","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of CCN2\/CTGF prevents heterotopic ossification in fibrodysplasia ossificans progressiva","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.09.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}